Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas A. Hilimire
Observed name:
Thomas Hilimire
Institutions:
University of South Carolina,
Senex Biotechnology (United States)
Observed institutions:
University of South Carolina,
University of Rochester Medicine,
Frederick National Laboratory for Cancer Research,
National Cancer Institute,
Center for Cancer Research,
Senex Biotechnology (United States),
University of Rochester
show all 7
ORCID:
0000-0001-7677-3016
Observed ORCID:
0000-0001-7677-3016
OpenAlex ID:
A5062505350
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
2018
·
David R. Calabrese
, Xiang Chen
, et al.
·
Nature Communications
·
180
PDF
Measuring RNA–Ligand Interactions with Microscale Thermophoresis
2018
·
Michelle H. Moon
, Thomas A. Hilimire
, et al.
·
Biochemistry
·
103
Machine Learning Informs RNA‐Binding Chemical Space**
2022
·
Kamyar Yazdani
, Deondre Jordan
, et al.
·
Angewandte Chemie International Edition
·
93
Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
2020
·
Karyn Schmidt
, Chase A. Weidmann
, et al.
·
Cell Reports
·
82
PDF
HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells
2017
·
Thomas A. Hilimire
, Jeffrey M. Chamberlain
, et al.
·
ACS Chemical Biology
·
54
PDF
High-Affinity Recognition of HIV-1 Frameshift-Stimulating RNA Alters Frameshifting in Vitro and Interferes with HIV-1 Infectivity
2014
·
Leslie O. Ofori
, Thomas A. Hilimire
, et al.
·
Journal of Medicinal Chemistry
·
45
N -Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA
2015
·
Thomas A. Hilimire
, Ryan P. Bennett
, et al.
·
ACS Chemical Biology
·
43
PDF
Small molecule microarray identifies inhibitors of tyrosyl-DNA phosphodiesterase 1 that simultaneously access the catalytic pocket and two substrate binding sites
2021
·
Xue Zhi Zhao
, Evgeny Kiselev
, et al.
·
Chemical Science
·
33
PDF
Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
2019
·
Jun-Gyu Park
, Ginés Ávila-Pérez
, et al.
·
Frontiers in Microbiology
·
31
PDF
Machine Learning Informs RNA‐Binding Chemical Space**
2022
·
Kamyar Yazdani
, Deondre Jordan
, et al.
·
Angewandte Chemie
·
28
PDF
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer
2024
·
Jing Li
, Thomas A. Hilimire
, et al.
·
Journal of Clinical Investigation
·
27
PDF
Peptides Derived from the Tight Junction Protein CLDN1 Disrupt the Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine
2019
·
Matthew G. Brewer
, Elizabeth A. Anderson
, et al.
·
Journal of Investigative Dermatology
·
21
PDF
Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
2020
·
Thomas A. Hilimire
, Aitor Nogales
, et al.
·
Pathogens
·
19
PDF
Enhancing the ligand efficiency of anti-HIV compounds targeting frameshift-stimulating RNA
2019
·
Viktoriya S. Anokhina
, John D. McAnany
, et al.
·
Bioorganic & Medicinal Chemistry
·
13
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors
2024
·
Xiaokai Ding
, Jiaxin Liang
, et al.
·
Proceedings of the National Academy of Sciences
·
12
Abstract 2357: Inhibition of CDK8/19 mediator kinase suppresses primary and metastatic growth of castration-resistant prostate cancer
2022
·
Jing Li
, Thomas Hilimire
, et al.
·
Cancer Research
·
1
CDK8/19 inhibition prevents adaptive resistance to CDK4/6 inhibitors in vitro and in vivo
2026
·
Zachary T. Mack
, Margarita Yastrebova
, et al.
·
Cell Reports Medicine
Correction for Piepenbrink et al., “Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies”
2024
·
Michael Piepenbrink
, Fatai Oladunni
, et al.
·
Microbiology Spectrum
Abstract A043: CDK8/19-regulated transcriptional reprogramming: a druggable driver of castration-resistant prostate cancer
2023
·
Jing Li
, Thomas Hilimire
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
19
Citation count:
785
H-index:
13
I10-index:
15
Year
Topic
Type